UB Paderborn / Katalog / Suche / in CDI

Correction to: Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance

Cancer and metastasis reviews, 2021-09, Vol.40 (3), p.863-864

2021

Volltextzugriff (PDF)

Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies

Cancers, 2023-06, Vol.15 (13), p.3312

2023

Volltextzugriff (PDF)

Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma

Current treatment options in oncology, 2024, Vol.25 (1), p.127-160

2024

Volltextzugriff (PDF)

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma

Nature communications, 2023-06, Vol.14 (1), p.3650-3650, Article 3650

2023

Volltextzugriff (PDF)

Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma Using a Modern Dual-Field Rotational Technique

International journal of radiation oncology, biology, physics, 2015-05, Vol.92 (1), p.183-191

2015

Volltextzugriff (PDF)

Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice

American journal of physiology. Lung cellular and molecular physiology, 2010-03, Vol.298 (3), p.L315-L323

2010

Volltextzugriff (PDF)

Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance

Cancer and metastasis reviews, 2021-09, Vol.40 (3), p.837-862

2021

Volltextzugriff (PDF)

A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence

Clinical epigenetics, 2022-12, Vol.14 (1), p.166, Article 166

2022

Volltextzugriff (PDF)

BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report

Case reports in oncology, 2022-09, Vol.15 (3), p.909-917

2022

Volltextzugriff (PDF)

Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma

Case reports in oncology, 2020-05, Vol.13 (2), p.508-514

2020

Volltextzugriff (PDF)

Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses

Cell reports methods, 2023-10, Vol.3 (10), p.100600-100600, Article 100600

2023

Volltextzugriff (PDF)

CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation

Dermatology and therapy, 2016-06, Vol.6 (2), p.251-263

2016

Volltextzugriff (PDF)

ETCTN 10476: A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without addition of cobimetinib in previously treated unresectable biliary tract cancer

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS639-TPS639

2023

Volltextzugriff (PDF)

Targeted therapies in advanced biliary tract cancers-a narrative review

Chinese Clinical Oncology, 2023-04, Vol.12 (2), p.14-14

2023

Volltextzugriff (PDF)

A phase I study of a mutant KRAS-targeted long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer and MMR-proficient metastatic colorectal cancer

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS814-TPS814

2023

Volltextzugriff (PDF)

A phase II study of atezolizumab (ATEZO) and bevacizumab (BEV) in combination with Y90 TARE in patients (pts) with hepatocellular carcinoma (HCC): Y90+/- BEAT

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS629-TPS629

2023

Volltextzugriff (PDF)

First-line stereotactic radiosurgery combined with systemic targeted and immune checkpoint inhibitor therapy in melanoma patients with newly diagnosed brain metastases

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e13577-e13577

2019

Volltextzugriff (PDF)

Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.558-558

2022

Volltextzugriff (PDF)

Abstract CT036: Safety and immunogenicity of a first-in-human mutant KRAS long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer: Preliminary analysis from a phase I study

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT036-CT036

2023

Volltextzugriff (PDF)

Abstract IA013: Intercepting pancreatic cancer development with mutant KRAS-targeted immunotherapy

Cancer research (Chicago, Ill.), 2022-11, Vol.82 (22_Supplement), p.IA013-IA013

2022

Volltextzugriff (PDF)

Abstract LB197: A pooled mutant KRAS peptide vaccine activates polyfunctional T cell responses in patients with resected pancreatic cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.LB197-LB197

2023

Volltextzugriff (PDF)

MLTI-03. FIRST-LINE STEREOTACTIC RADIOSURGERY COMBINED WITH SYSTEMIC TARGETED AND IMMUNE CHECKPOINT INHIBITOR THERAPY IN MELANOMA PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES

Neuro-oncology advances, 2019-08, Vol.1 (Supplement_1), p.i14-i15

2019

Volltextzugriff (PDF)

Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice

American journal of physiology. Lung cellular and molecular physiology, 2010, Vol.42 (3)

2010

Volltextzugriff (PDF)

The clinical application of immuno-therapeutics

Clinical Immuno-Oncology - E-Book, 2023

Niederhuber, John E

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Correction to: Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance

Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies

Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma

Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma Using a Modern Dual-Field Rotational Technique

Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice

Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance

A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence

BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report

Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma

Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses

CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation

ETCTN 10476: A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without addition of cobimetinib in previously treated unresectable biliary tract cancer

Targeted therapies in advanced biliary tract cancers-a narrative review

A phase I study of a mutant KRAS-targeted long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer and MMR-proficient metastatic colorectal cancer

Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy

A phase II study of atezolizumab (ATEZO) and bevacizumab (BEV) in combination with Y90 TARE in patients (pts) with hepatocellular carcinoma (HCC): Y90+/- BEAT

First-line stereotactic radiosurgery combined with systemic targeted and immune checkpoint inhibitor therapy in melanoma patients with newly diagnosed brain metastases

Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma

Abstract CT036: Safety and immunogenicity of a first-in-human mutant KRAS long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer: Preliminary analysis from a phase I study

Abstract IA013: Intercepting pancreatic cancer development with mutant KRAS-targeted immunotherapy

Abstract LB197: A pooled mutant KRAS peptide vaccine activates polyfunctional T cell responses in patients with resected pancreatic cancer

MLTI-03. FIRST-LINE STEREOTACTIC RADIOSURGERY COMBINED WITH SYSTEMIC TARGETED AND IMMUNE CHECKPOINT INHIBITOR THERAPY IN MELANOMA PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES

Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice

The clinical application of immuno-therapeutics

Suchergebnisse filtern